[
    "d air dried. The amounts of TC and TG were measured using the kit according to the manufacturer's instructions. An internal standard control was used to correct the error.</p>Bone densitometry using micro-CT: femur was fixed in 1X DPBS containing 3% formaldehyde for two weeks. After one week the fixation solution was changed. The femur density was measured by Siemens Inveon Micro-CT. HU2000 values were analyzed using Inveon Research Workplace (IRW) under the following measurement conditions: 80KVP,500mA,1500ms exposure time; CCD reader installation: 2048 axes, 2048 bins; trans-axis FOV:19.03mm, shaft: 19.03mm, pixel size: 9.29 \u03bcm. </p>Cell lysate extraction, western blot, total RNA extraction and RT-qPCR: cells were harvested and lysed in RIPA buffer or 1X DPBS containing 1% triton-X100 and protease inhibitor cocktail. Total protein concentration was measured using Bio-rad protein staining dye. Western blotting was performed using nitrocellulose membranes (Millipore) and a Bio-rad semi-dry transfer system, following standard protocols. Total RNA was extracted using RNA extraction solution (sigma). RT-qPCR was performed using Roche Sybr qPCR kit and ABI7900HT PCR apparatus using the following procedure: 95\u2103for 10min, then 40 cycles of 95\u2103for 10sec and 60\u2103for 1min.</p>Statistical analysis: in the tables and graphs, the results are expressed as average +STDEV. Asterisks indicate statistically significant differences calculated using the two-tailed student's t test.</p>Example 2 binding assay of mandipropamid and dinordrin</p>Dinordrin has similar results to the mandipropionate except that it has a-H at the R6 position. We found that 50nM dinordrin blocked 0.5nM[H <sup>3</sup> -E2]63.2.+ -. 5.7% of the binding to 1. Mu.g of GST-ER- \u03b1 -LBD on the beads. In contrast, the mandipropargyl carbon loss esters do not cause blocking [ H <sup>3</sup> -E2]Inhibition of binding to 1. Mu.g of GST-ER-alpha-LBD. </p>In addition, 6. Mu.M dinordrin increased transcription of Bcl-2mRNA by 147.2% + -22.73% (P &lt; 0.001). In contrast, a statistically insignificant difference of 3.18% + -3.22% caused by mandipropamidic carbon loss was measured in MCF-7 cells using RT-qPCR.</p>The results show that R6-CH3 (as opposed to-H) is essential for the unique functional characteristics of the mandipropargyl carbon loss ester.</p>Reference to the literature</p>1.Boonyaratanakornkit,V.,Steriods.76,877-884,(2011).</p>Mauvis-jarvis, F., clegg, DJ. and Hevener, AI., endocrine reviews.34 (3), 309-338 (2013)</p>Kuang, lg, zhang, XT., xie, y, et al, molecular endocrinology 24 (4), 709-721 (2010)</p>Rao, J., jiang, XM., wang, Y. And Chen, B., journal of Steroid Biochemistry and Molecular biology 127,231-237 (2011)</p>Revankark, CM, cimno D, sklar, LA., arterburn, JB. and Prossnitz, ER., science 307 (11), 1625-1630 (2005)</p>Nilsson, BO., olde, B. And Leeb-Lundberg, LF.. British Journal of Pharmacology 163.1131-1139 (2011)</p>Zhang, xt, ding, l., kang, LG. and Wang, y., PLos one.7 (1), e30",
    "hou, p.q., and Yu, w.j., tumor,9,197 (1989).</p>Ma, Z.C., lou, L.G., zhang, Z.and Bin, X, acta Pharmacol.sin,21,939 (2000).</p>Li r.l., lee, d.y., cheng, q.l., U.S. patent 5001120 (1991).</p>Mehta, r.r., jenco, j.m., and Chatterton, r.t., steroids,38,679 (1981).</p>Nehra, R., riggins, RB., shajahan, AN et al, FASEB J.24 (6) 2040-55 (2010)</p>Watanabe, T., inoue, S., hiroi, H, orimo, A, et al, mol.cell.biol.18.442-9 (1998)</p>Butler, WB., kelsey, SJ., castagna, M. And Blumberg, PM.. Cancer Res.41 (1). 82-8 (1981)</p>22.Cesarone G,Garofalo C,Abrams MT, et al, J Cell biochem.98 (2). 440-50 (2006)</p>Kang, lg, zhang, XT., xie, y., tu, YP., et al mol</p>Zhang, j, li, g, li, z, yu, x, zhang, h, etc., steroids.77 (6) 666-73 (2012) </p>Melchiori, A., mortarini, R., carlone, S., et al, exp.cell Res.,219,233-242 (1995).</p>Morini, M., mortolese, M., ferrari, N., ghiorzo, F., et al, int.J. cancer:87,336-342 (2000)</p>Garrido P, mor n J, alonso A, gonz lez S, et al Endocrinology 154 (6): 1979-89 (2013)</p>28.Garris DR. And Garris, BL.. Cell Tissue Res.319 (2). 231-42 (2005)</p>Wang Q., jiang, l., wang, j. Et al, hepatology 49.1166-75 (2009)</p>Szatkowski c., parks, JB., quadrid-Ahidouch, h., et al mol. Cancer.9.156 (2010)</p>31.Fukatsu K,Bannai H,Inoue T,Mikoshiba K.J Neurochem.114(6):1720-33.(2010)</p>Cabodi, S., moro, L., baj, G., et al, J Cell Sci.117.1603-11 (2004)</p>33.Bigarella CL,Borges L,Costa FF,Saad ST.Biochim Biophys Acta.1793(5):806-16.(2009)</p>34.Filardo EJ,Quinn JA,Bland KI,Frackelton Jr.AR.Mol.Endocrinol.14:1649-60(2000)</p>35.Filardo EJ,Graeber CT,Quinn JA et al Clin. Cancer Res.12:6359-66 (2006)</p>36.Pedram A,Razandi M,Levin ER.Mol.Endocrinol.20:1996-2009(2006)</p>Otto C, rohde-schuzl B, schwarz GFuchs I, et al Endocrinology 149:4846-56 (2008)</p>38.Edward J,Filardo and Thomas P.endocrinology.153 (7): 2953-62 (2012)</p>Geary, N., asarian, L., korach, KS et al, endocrinology 142,4751-7 (2001)</p>Ohlsson, C., hellberg, N., parini, P. Et al, biochem. Biophys. Res. Commun.278,640-5 (2000)</p>Langer, G., bader, B., meoli, L., et al, steroids.75,603-10 (2010)</p>White, C., li, C., yang, J., et al, nat.Cell biol.7 (10), 1021-8 (2005)</p>43.Muthusamy T,Murugesan P,Balasubramanian K.Metabolism.58(11):1581-92(2009)</p>Ceusta, PG, suarez, JM., garcia, AA, et al, endocrinology (2013) </p>Gorres, bk, bomhoff, GL., morris, JK. and Geiger, pc.j physiol (2013)</p>"
]